Condition: FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma · FIGO Grade 2 Endometrial Endometrioid Adenocarcinoma · Stage IA1 Endometrial Cancer FIGO 2023 · Sponsor: Mayo Clinic
This study evaluates whether isolated tumor cells in the first lymph nodes near the tumor can tell researchers something important about the future of patients with a certain type of endometrial (uterine) cancer.
This description comes directly from the study's public registry record.
Clinical Trials Referral Office · 855-776-0015 · mayocliniccancerstudies@mayo.edu
Always discuss trial participation with your own doctor first.
| Mayo Clinic in Rochester | Rochester, Minnesota, United States | Recruiting |
| Memorial Sloan Kettering Cancer Center | New York, New York, United States | Recruiting |
| Houston Methodist Hospital | Houston, Texas, United States | Recruiting |
| Medical University of Vienna | Vienna, Austria | Recruiting |
| AC Camargo Cancer Center | São Paulo, Brazil | Recruiting |
| Sunnybrook Health Sciences, University of Toronto | Toronto, Ontario, Canada | Recruiting |
| Hopital Maisonneuve Rosemont | Montreal, Quebec, Canada | Recruiting |
| Institut Universitaire du Cancer Toulouse Oncopole | Toulouse, France | Not Yet Recruiting |
| University Hospital Essen | Essen, Germany | Not Yet Recruiting |
| Meir Medical Center, Faculty of Medicine - Tel-Aviv University | Kefar Sava, Israel | Not Yet Recruiting |
| Ospedale Michele e Pietro Ferrero | Verduno, CN, Italy | Not Yet Recruiting |
| IRCCS Fondazione San Gerardo dei Tintori | Monza, MB, Italy | Not Yet Recruiting |
+ 8 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06689956